Exact Mass: 576.4029

beta-Sitosterol 3-O-beta-D-galactopyranoside

C35H60O6 (576.439)

Daucosterol is a steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. It has a role as a plant metabolite. It is a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a sitosterol. It derives from a hydride of a stigmastane. Sitogluside is a natural product found in Ophiopogon intermedius, Ophiopogon jaburan, and other organisms with data available. beta-Sitosterol 3-O-beta-D-galactopyranoside is found in herbs and spices. beta-Sitosterol 3-O-beta-D-galactopyranoside is a constituent of Hibiscus sabdariffa (roselle) leaves. C308 - Immunotherapeutic Agent Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid

C38H56O4 (576.4178)

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid is an intermediate in the biosynthesis of Ubiquinone. It is a substrate for Hexaprenyldihydroxybenzoate methyltransferase (mitochondrial). [HMDB] 3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid is an intermediate in the biosynthesis of Ubiquinone. It is a substrate for Hexaprenyldihydroxybenzoate methyltransferase (mitochondrial).

2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone

C38H56O4 (576.4178)

2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is created from 2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis monooxygenase Coq7 [EC:1.14.13.-]. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is then converted to ubiquinone by hexaprenyldihydroxybenzoate methyltransferase [EC:2.1.1.114]. [HMDB] 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is created from 2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis monooxygenase Coq7 [EC:1.14.13.-]. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is then converted to ubiquinone by hexaprenyldihydroxybenzoate methyltransferase [EC:2.1.1.114].

Campesteryl ferulate

C38H56O4 (576.4178)

Campesteryl ferulate is found in cereals and cereal products. Campesteryl ferulate is a constituent of various cereal grains Constituent of various cereal grains

Schottenol 3-glucoside

C35H60O6 (576.439)

Constituent of citron-melon fruits (Citrullus lanatus variety citroides). Schottenol 3-glucoside is found in watermelon, fruits, and spinach. Schottenol 3-glucoside is found in fruits. Schottenol 3-glucoside is a constituent of citron-melon fruits (Citrullus lanatus var. citroides).

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.439)

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.439)

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.439)

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.439)

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.439)

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.439)

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

C35H60O6 (576.439)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.439)

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

C35H60O6 (576.439)

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.439)

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

C35H60O6 (576.439)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

C35H60O6 (576.439)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C35H60O6 (576.439)

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C35H60O6 (576.439)

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0)

C35H60O6 (576.439)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

24-Methylcholesterol ferulate

C38H56O4 (576.4178)

24-methylcholesterol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methylcholesterol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methylcholesterol ferulate can be found in corn, which makes 24-methylcholesterol ferulate a potential biomarker for the consumption of this food product.

24-Methyllathosterol ferulate

C38H56O4 (576.4178)

24-methyllathosterol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methyllathosterol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methyllathosterol ferulate can be found in corn, which makes 24-methyllathosterol ferulate a potential biomarker for the consumption of this food product.

24-Methylenecholestanol ferulate

C38H56O4 (576.4178)

24-methylenecholestanol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methylenecholestanol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methylenecholestanol ferulate can be found in corn, which makes 24-methylenecholestanol ferulate a potential biomarker for the consumption of this food product.

Coriandrinol

C35H60O6 (576.439)

Coriandrinol belongs to stigmastanes and derivatives class of compounds. Those are sterol lipids with a structure based on the stigmastane skeleton, which consists of a cholestane moiety bearing an ethyl group at the carbon atom C24. Coriandrinol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Coriandrinol can be found in coriander, which makes coriandrinol a potential biomarker for the consumption of this food product. Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

MCULE-8628710105

C30H56O10 (576.3873)

Bacosterol-3-O-beta-D-glucopyranoside

C35H60O6 (576.439)

Thorexanthin

C41H52O2 (576.3967)

1,3-Diacetyl-24-epi-polacandrin

C34H56O7 (576.4026)

beta-Sitosteryl-D-glucoside

C35H60O6 (576.439)

3alpha-acetoxy-21S,25-dimethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S-diol|chisopanin F

C34H56O7 (576.4026)

3alpha-acetoxy-21R-ethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S,25-triol|chisopanin G

C34H56O7 (576.4026)

beta-sitosterol-delta-glucopyranoside|beta-sitosteryl-beta-D-glucoside|sitosterol-beta-D-glucoside

C35H60O6 (576.439)

SCHEMBL13641595

C38H48N4O (576.3828)

sitosterol-3beta-glucopyranoside

C35H60O6 (576.439)

SCHEMBL11913139

C35H60O6 (576.439)

Methyl-2alpha-benzoyloxy-3beta-hydroxy-urs-12-en-28-oat

C37H52O5 (576.3815)

3alpha-hydroxy-28beta-methoxy-13alpha-ursan-28,12beta-epoxide 3-benzoate

C38H56O4 (576.4178)

Venturicidin X

C34H56O7 (576.4026)

3beta-hydroxy-27-benzoyloxylup-20(29)-en-28-oic acid

C37H52O5 (576.3815)

Raspacionin

C34H56O7 (576.4026)

beta-sitosterol beta-D-glucopyranoside

C35H60O6 (576.439)

(24R)-ergost-5-en-11-oxo-3beta-ol-alpha-D-glucopyranoside|argyroside

C34H56O7 (576.4026)

C34H56O7

C34H56O7 (576.4026)

4-O-acetyl-3-O-[beta-D-arabinopyranosyloxy]-cholest-5-ene-3beta,19-diol

C34H56O7 (576.4026)

beta-sitosterol-3-O-beta-D-glucopyranoside

C35H60O6 (576.439)

beta-sitosterol-3-O-beta-D-glucoside

C35H60O6 (576.439)

agladoral E

C34H56O7 (576.4026)

Daucosterol

C35H60O6 (576.439)

Daucosterol is a steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. It has a role as a plant metabolite. It is a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a sitosterol. It derives from a hydride of a stigmastane. Sitogluside is a natural product found in Ophiopogon intermedius, Ophiopogon jaburan, and other organisms with data available. A steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. C308 - Immunotherapeutic Agent Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

21,24-diacetoxylanostan-3,22,25-triol|terresterol

C34H56O7 (576.4026)

3beta-O-(alpha-L-fucopyranosyl)-11-hydroxy-24-methylene-9,11-secocholest-5-en-9-one|sinularoside A

C34H56O7 (576.4026)

10,10-Methylenebis(norvallesamidine)

C39H52N4 (576.4192)

30-(4-hydroxybenzoyloxy)-11alpha-hydroxylupane-20(29)-en-3-one

C37H52O5 (576.3815)

beta-sitosterol-beta-D-glucoside

C35H60O6 (576.439)

beta-Sitosterylglucosid

C35H60O6 (576.439)

beta-sitosterol-beta-D-glucoside|stigmast-6-en-3-O-beta-(D-glucopyranoside)

C35H60O6 (576.439)

24-methylenecholest-5-en-3beta,7beta,16beta-triol-3-O-alpha-L-fucoside|24-methylenecholest-5-ene-3beta,7beta,16beta-triol-3-O-alpha-L-fucopyranoside

C34H56O7 (576.4026)

geniculatoside F|stigmast-16-en-3alpha-O-(beta-D-galactopyranoside)

C35H60O6 (576.439)

Phomenolactone

C34H56O7 (576.4026)

24-methylenecholestanol ferulate

C38H56O4 (576.4178)

(24R,S)-24-methyllathosterol ferulate

C38H56O4 (576.4178)

Phe Lys Leu Arg

C28H48N8O5 (576.3747)

5-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-3-hydroxydecanoic acid

C30H56O10 (576.3873)

3-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid

C30H56O10 (576.3873)

3-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid [IIN-based on: CCMSLIB00000848124]

C30H56O10 (576.3873)

3-[5-(3,5-dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid [IIN-based: Match]

C30H56O10 (576.3873)

PA(12:0/15:1(9Z))

C30H57O8P (576.3791)

PA(13:0/14:1(9Z))

C30H57O8P (576.3791)

PA(14:1(9Z)/13:0)

C30H57O8P (576.3791)

PA(15:1(9Z)/12:0)

C30H57O8P (576.3791)

PA(P-16:0/12:0)

C31H61O7P (576.4155)

stigmast-5-en-3beta-ol 3-0-beta-D-glucopyranoside

C35H60O6 (576.439)

beta-Sitosterol 3-O-beta-D-galactopyranoside

C35H60O6 (576.439)

Schottenol glucoside

C35H60O6 (576.439)

Campesteryl ferulate

C38H56O4 (576.4178)

Exophilin A1

C30H56O10 (576.3873)

PA 27:1

C30H57O8P (576.3791)

PA O-28:1

C31H61O7P (576.4155)

glucoclionasterol

C35H60O6 (576.439)

ST 29:1;O;Hex

C35H60O6 (576.439)

Oryzanol

C38H56O4 (576.4178)

Bisdehydro-beta-carotene-2-carboxylic acid

C41H52O2 (576.3967)

Clathriaxanthin

C41H52O2 (576.3967)

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid

C38H56O4 (576.4178)

Menabitan

C37H56N2O3 (576.4291)

Aluminum,tris(2,2,6,6-tetramethyl-3,5-heptanedionato-kO3,kO5)-, (OC-6-11)-

C33H57AlO6 (576.397)

N,N-dimethyl-4-[2-(1-octadecylpyridin-1-ium-2-yl)ethenyl]aniline,perchlorate

C33H53ClN2O4 (576.3694)

3-Hydroxy-5-(3-hydroxy-5-(3,5-dihydroxydecanoyloxy)decanoyloxy)decanoic acid

C30H56O10 (576.3873)

Sitosterol glucoside

C35H60O6 (576.439)

solasodine 3-O-beta-D-glucopyranoside

C33H54NO7+ (576.39)

Solasodine galactoside

C33H54NO7+ (576.39)

24-Methyllathosterol ferulate

C38H56O4 (576.4178)

[(3S,10R,13R,17R)-17-[(2R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178)

2-(Hydroxymethyl)-6-(5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2-piperidin-1-ium]-16-yl)oxyoxane-3,4,5-triol

C33H54NO7+ (576.39)

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.439)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.439)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.439)

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.439)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.439)

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.439)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.439)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.439)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C35H60O6 (576.439)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C35H60O6 (576.439)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

C35H60O6 (576.439)

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C35H60O6 (576.439)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

C35H60O6 (576.439)

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C35H60O6 (576.439)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

C35H60O6 (576.439)

2-[[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

solasodine 3-beta-D-glucoside

C33H54NO7+ (576.39)

C35 phosphodolichol

C35H61O4P (576.4307)

3-[5-(3,5-Dihydroxydecanoyloxy)-3-hydroxydecanoyl]oxy-5-hydroxydecanoic acid

C30H56O10 (576.3873)

NAGlySer 16:4/11:0

C32H52N2O7 (576.3774)

2,3-dihydroxypropyl [2-hydroxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propyl] hydrogen phosphate

C30H57O8P (576.3791)

Mgdg O-19:0_3:0

C31H60O9 (576.4237)

Mgdg O-9:0_13:0

C31H60O9 (576.4237)

Mgdg O-14:0_8:0

C31H60O9 (576.4237)

Mgdg O-18:0_4:0

C31H60O9 (576.4237)

Mgdg O-8:0_14:0

C31H60O9 (576.4237)

Mgdg O-13:0_9:0

C31H60O9 (576.4237)

Mgdg O-16:0_6:0

C31H60O9 (576.4237)

Mgdg O-17:0_5:0

C31H60O9 (576.4237)

Mgdg O-20:0_2:0

C31H60O9 (576.4237)

Mgdg O-15:0_7:0

C31H60O9 (576.4237)

Mgdg O-12:0_10:0

C31H60O9 (576.4237)

Mgdg O-11:0_11:0

C31H60O9 (576.4237)

Mgdg O-10:0_12:0

C31H60O9 (576.4237)

PE-Cer 14:1;2O/14:0

C30H61N2O6P (576.4267)

PE-Cer 13:1;2O/15:0

C30H61N2O6P (576.4267)

PE-Cer 12:1;2O/16:0

C30H61N2O6P (576.4267)

PE-Cer 15:1;2O/13:0

C30H61N2O6P (576.4267)

PE-Cer 13:0;2O/15:1

C30H61N2O6P (576.4267)

PE-Cer 15:0;2O/13:1

C30H61N2O6P (576.4267)

PE-Cer 16:1;2O/12:0

C30H61N2O6P (576.4267)

PE-Cer 14:0;2O/14:1

C30H61N2O6P (576.4267)

PE-Cer 12:0;2O/16:1

C30H61N2O6P (576.4267)

PE-Cer 15:1;2O/12:1;O

C29H57N2O7P (576.3903)

PE-Cer 14:2;2O/13:0;O

C29H57N2O7P (576.3903)

PE-Cer 15:2;2O/12:0;O

C29H57N2O7P (576.3903)

PE-Cer 12:2;2O/15:0;O

C29H57N2O7P (576.3903)

PE-Cer 12:1;2O/15:1;O

C29H57N2O7P (576.3903)

PE-Cer 14:1;2O/13:1;O

C29H57N2O7P (576.3903)

PE-Cer 13:1;2O/14:1;O

C29H57N2O7P (576.3903)

PE-Cer 13:2;2O/14:0;O

C29H57N2O7P (576.3903)

[(E)-2-acetamido-3-hydroxytricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(butanoylamino)-3-hydroxyhenicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(nonanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(hexadecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(heptadecanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(pentanoylamino)icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(hexanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(heptanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(octanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(propanoylamino)docos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(decanoylamino)-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(undecanoylamino)tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(pentadecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(tridecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-2-(dodecanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(E)-3-hydroxy-2-(tetradecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

PEtOH 25:1

C30H57O8P (576.3791)

PMeOH 13:0_13:1

C30H57O8P (576.3791)

PMeOH 12:0_14:1

C30H57O8P (576.3791)

Fahfa 16:4/22:5

C38H56O4 (576.4178)

Fahfa 22:6/16:3

C38H56O4 (576.4178)

Fahfa 18:5/20:4

C38H56O4 (576.4178)

[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate

C30H56O10 (576.3873)

[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] dodecanoate

C30H56O10 (576.3873)

[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octadecanoate

C30H56O10 (576.3873)

[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptadecanoate

C30H56O10 (576.3873)

[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate

C30H56O10 (576.3873)

[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonadecanoate

C30H56O10 (576.3873)

[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate

C30H56O10 (576.3873)

[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentadecanoate

C30H56O10 (576.3873)

[1-Decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] undecanoate

C30H56O10 (576.3873)

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate

C30H57O8P (576.3791)

(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate

C30H57O8P (576.3791)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate

C30H57O8P (576.3791)

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-nonadec-9-enoate

C30H57O8P (576.3791)

(1-phosphonooxy-3-propanoyloxypropan-2-yl) (Z)-tetracos-13-enoate

C30H57O8P (576.3791)

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate

C30H57O8P (576.3791)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-tetradec-9-enoate

C30H57O8P (576.3791)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-hexadec-9-enoate

C30H57O8P (576.3791)

[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] tetradecanoate

C30H57O8P (576.3791)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-pentadec-9-enoate

C30H57O8P (576.3791)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate

C30H57O8P (576.3791)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C37H52O5 (576.3815)

N-(decanoyl)-4E-pentadecasphingenine-1-phosphocholine

C30H61N2O6P (576.4267)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-hexadec-7-enoate

C30H57O8P (576.3791)

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] (E)-heptadec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-tetradec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-hexadec-9-enoate

C30H57O8P (576.3791)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-pentadec-9-enoate

C30H57O8P (576.3791)

[(E,2S,3R)-2-(decanoylamino)-3-hydroxypentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-pentadec-9-enoate

C30H57O8P (576.3791)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-hexadec-9-enoate

C30H57O8P (576.3791)

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] (E)-heptadec-9-enoate

C30H57O8P (576.3791)

[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] undecanoate

C30H56O10 (576.3873)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-tetradec-9-enoate

C30H57O8P (576.3791)

[1-carboxy-3-[2-hydroxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO6+ (576.4264)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-hexadec-7-enoate

C30H57O8P (576.3791)

2-[[(2R)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

[(2S)-1-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] undecanoate

C30H56O10 (576.3873)

2-[[2-butanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

[1-carboxy-3-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium

C33H54NO7+ (576.39)

2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

2-[[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

[1-carboxy-3-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium

C33H54NO7+ (576.39)

2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

2-[[2-acetyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4029)

3-demethylubiquinone-6

C38H56O4 (576.4178)

A polyprenylbenzoquinone that is fumigatin which is substituted by an all-trans-hexaprenyl group at position 6.

C35-phosphodolichol

C35H61O4P (576.4307)

A dolichyl phosphate in which the dolichyl moiety contains six prenyl units

1-dodecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphate

C30H57O8P (576.3791)

1-tridecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C30H57O8P (576.3791)

1-(9Z-tetradecenoyl)-2-tridecanoyl-glycero-3-phosphate

C30H57O8P (576.3791)

1-(9Z-pentadecenoyl)-2-dodecanoyl-glycero-3-phosphate

C30H57O8P (576.3791)

FAHFA 12:2/O-26:7

C38H56O4 (576.4178)

FAHFA 12:3/O-26:6

C38H56O4 (576.4178)

FAHFA 12:4/O-26:5

C38H56O4 (576.4178)

FAHFA 13:2/O-25:7

C38H56O4 (576.4178)

FAHFA 13:3/O-25:6

C38H56O4 (576.4178)

FAHFA 13:4/O-25:5

C38H56O4 (576.4178)

FAHFA 14:2/O-24:7

C38H56O4 (576.4178)

FAHFA 14:3/O-24:6

C38H56O4 (576.4178)

FAHFA 14:4/O-24:5

C38H56O4 (576.4178)

FAHFA 15:2/O-23:7

C38H56O4 (576.4178)

FAHFA 15:3/O-23:6

C38H56O4 (576.4178)

FAHFA 15:4/O-23:5

C38H56O4 (576.4178)

FAHFA 15:5/O-23:4

C38H56O4 (576.4178)

FAHFA 16:2/O-22:7

C38H56O4 (576.4178)

FAHFA 16:3/O-22:6

C38H56O4 (576.4178)

FAHFA 16:4/O-22:5

C38H56O4 (576.4178)

FAHFA 16:5/O-22:4

C38H56O4 (576.4178)

FAHFA 17:2/O-21:7

C38H56O4 (576.4178)

FAHFA 17:3/O-21:6

C38H56O4 (576.4178)

FAHFA 17:4/O-21:5

C38H56O4 (576.4178)

FAHFA 17:5/O-21:4

C38H56O4 (576.4178)

FAHFA 18:3/O-20:6

C38H56O4 (576.4178)

FAHFA 18:4/O-20:5

C38H56O4 (576.4178)

FAHFA 18:5/O-20:4

C38H56O4 (576.4178)

FAHFA 18:6/O-20:3

C38H56O4 (576.4178)

FAHFA 19:3/O-19:6

C38H56O4 (576.4178)

FAHFA 19:4/O-19:5

C38H56O4 (576.4178)

FAHFA 19:5/O-19:4

C38H56O4 (576.4178)

FAHFA 19:6/O-19:3

C38H56O4 (576.4178)

FAHFA 20:3/O-18:6

C38H56O4 (576.4178)

FAHFA 20:4/O-18:5

C38H56O4 (576.4178)

FAHFA 20:5/O-18:4

C38H56O4 (576.4178)

FAHFA 20:6/O-18:3

C38H56O4 (576.4178)

FAHFA 21:4/O-17:5

C38H56O4 (576.4178)

FAHFA 21:5/O-17:4

C38H56O4 (576.4178)

FAHFA 21:6/O-17:3

C38H56O4 (576.4178)

FAHFA 21:7/O-17:2

C38H56O4 (576.4178)

FAHFA 22:4/O-16:5

C38H56O4 (576.4178)

FAHFA 22:5/O-16:4

C38H56O4 (576.4178)

FAHFA 22:6/O-16:3

C38H56O4 (576.4178)

FAHFA 22:7/O-16:2

C38H56O4 (576.4178)

FAHFA 23:4/O-15:5

C38H56O4 (576.4178)

FAHFA 23:5/O-15:4

C38H56O4 (576.4178)

FAHFA 23:6/O-15:3

C38H56O4 (576.4178)

FAHFA 23:7/O-15:2

C38H56O4 (576.4178)

FAHFA 24:5/O-14:4

C38H56O4 (576.4178)

FAHFA 24:6/O-14:3

C38H56O4 (576.4178)

FAHFA 24:7/O-14:2

C38H56O4 (576.4178)

FAHFA 25:5/O-13:4

C38H56O4 (576.4178)

FAHFA 25:6/O-13:3

C38H56O4 (576.4178)

FAHFA 25:7/O-13:2

C38H56O4 (576.4178)

FAHFA 26:5/O-12:4

C38H56O4 (576.4178)

FAHFA 26:6/O-12:3

C38H56O4 (576.4178)

FAHFA 26:7/O-12:2

C38H56O4 (576.4178)

FAHFA 38:9;O

C38H56O4 (576.4178)

MGDG 10:0_11:0

C30H56O10 (576.3873)

MGDG 21:0

C30H56O10 (576.3873)

MGDG O-21:1;O

C30H56O10 (576.3873)

MGDG O-22:0

C31H60O9 (576.4237)

MGMG 22:0

C31H60O9 (576.4237)

MGGA 21:0

C30H56O10 (576.3873)

PA O-14:0/14:1

C31H61O7P (576.4155)

PA O-14:1/14:0

C31H61O7P (576.4155)

PA O-16:0/11:2;O

C30H57O8P (576.3791)

PA O-16:1/12:0

C31H61O7P (576.4155)

PA O-18:1/10:0

C31H61O7P (576.4155)

PA O-27:2;O

C30H57O8P (576.3791)

PA P-14:0/14:0

C31H61O7P (576.4155)

PA P-14:0/14:0 or PA O-14:1/14:0

C31H61O7P (576.4155)

PA P-16:0/12:0

C31H61O7P (576.4155)

PA P-16:0/12:0 or PA O-16:1/12:0

C31H61O7P (576.4155)

PA P-18:0/10:0

C31H61O7P (576.4155)

PA P-18:0/10:0 or PA O-18:1/10:0

C31H61O7P (576.4155)

PA P-18:0/9:1;O

C30H57O8P (576.3791)

PA P-28:0

C31H61O7P (576.4155)

PA P-28:0 or PA O-28:1

C31H61O7P (576.4155)

PA 10:0_17:1

C30H57O8P (576.3791)

PA 11:0_16:1

C30H57O8P (576.3791)

PA 12:0_15:1

C30H57O8P (576.3791)

PA 13:0_14:1

C30H57O8P (576.3791)

PA 23:0/4:1

C30H57O8P (576.3791)

LPEth 26:1

C31H61O7P (576.4155)

LPM 27:1

C31H61O7P (576.4155)

PEth 25:1

C30H57O8P (576.3791)

PM 26:1

C30H57O8P (576.3791)

Hexaprenylmethylhydroxymethoxybenzoquinone

C38H56O4 (576.4178)

CerPE 14:0;O2/14:1

C30H61N2O6P (576.4267)

CerPE 14:1;O2/14:0

C30H61N2O6P (576.4267)

CerPE 14:2;O2/13:0;O

C29H57N2O7P (576.3903)

CerPE 15:1;O2/13:0

C30H61N2O6P (576.4267)

CerPE 15:2;O2/12:0;O

C29H57N2O7P (576.3903)

CerPE 16:1;O2/12:0

C30H61N2O6P (576.4267)

CerPE 16:2;O2/11:0;O

C29H57N2O7P (576.3903)

CerPE 17:1;O2/11:0

C30H61N2O6P (576.4267)

CerPE 17:2;O2/10:0;O

C29H57N2O7P (576.3903)

CerPE 18:1;O2/10:0

C30H61N2O6P (576.4267)

CerPE 27:2;O2;O

C29H57N2O7P (576.3903)

CerPE 28:1;O2

C30H61N2O6P (576.4267)

SM 14:1;O2/11:0

C30H61N2O6P (576.4267)

SM 14:2;O2/10:0;O

C29H57N2O7P (576.3903)

SM 15:1;O2/10:0

C30H61N2O6P (576.4267)

SM 24:2;O2;O

C29H57N2O7P (576.3903)

SM 25:1;O2

C30H61N2O6P (576.4267)

ST 28:1;O;GlcA

C34H56O7 (576.4026)

ST 28:2;O2;Hex

C34H56O7 (576.4026)

(4r,6r)-4-hydroxy-6-[(1e,4r,5e,8r,9e,11s,12r,13e,15z)-4,8,12,16-tetrahydroxy-11,13-dimethyl-15-[(2r,4s,6s)-2,4,6-trimethyloctylidene]hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4026)

7-(acetyloxy)-11-hydroxy-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate

C34H56O7 (576.4026)

4-hydroxy-6-[(1e,5e,9e,13e,15z)-4,8,12,16-tetrahydroxy-11,13-dimethyl-15-(2,4,6-trimethyloctylidene)hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4026)

(6r)-6-methoxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-one

C41H52O2 (576.3967)

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

[(1s,4r,12r,16s,17s)-17-hydroxy-12-methyl-8-oxapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5(9),6,10-trien-17-yl]methyl (9z,12z)-octadeca-9,12-dienoate

C38H56O4 (576.4178)

6-{[9a-(hydroxymethyl)-11a-methyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C34H56O7 (576.4026)

[7-(acetyloxy)-8,9-dihydroxy-1-(6-hydroxy-6-methylhept-4-en-2-yl)-3a,3b,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-6-yl]methyl acetate

C34H56O7 (576.4026)

4-hydroxy-6-[4,8,12,16-tetrahydroxy-11,13-dimethyl-15-(2,4,6-trimethyloctylidene)hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4026)

(1s,4r,5r,8r,10r,13r,14r,16r,17s,18s,19s,20r,23r)-23-methoxy-4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[14.6.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl benzoate

C38H56O4 (576.4178)

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(3r,5ar,6r,7s,9ar)-6-{2-[(3r,5ar,6s,9ar)-3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4026)

(3r,5r)-3-{[(3r,5r)-5-{[(3r,5r)-3,5-dihydroxydecanoyl]oxy}-3-hydroxydecanoyl]oxy}-5-hydroxydecanoic acid

C30H56O10 (576.3873)

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(3r,5r,6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-7-(acetyloxy)-2,5-dihydroxy-2-methylheptan-3-yl acetate

C34H56O7 (576.4026)

(3s,5as,6s,7r,9as)-6-{2-[(3s,5as,6r,9as)-3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4026)

1-[5-(1,2-dihydroxy-2-methylpropyl)-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

1-(5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthren-10-one

C34H56O7 (576.4026)

(1r,3as,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178)

4-hydroxy-1-[5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthren-10-one

C34H56O7 (576.4026)

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

6-methoxy-2,4,4-trimethyl-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,3,4-trimethylphenyl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-one

C41H52O2 (576.3967)

5-({5-[(3,5-dihydroxydecanoyl)oxy]-3-hydroxydecanoyl}oxy)-3-hydroxydecanoic acid

C30H56O10 (576.3873)

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

23-methoxy-4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[14.6.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl benzoate

C38H56O4 (576.4178)

[(1r,3ar,3br,5ar,6r,7r,8r,9r,9ar,9bs,11ar)-7-(acetyloxy)-8,9-dihydroxy-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-3a,3b,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-6-yl]methyl acetate

C34H56O7 (576.4026)

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4026)

3-(acetyloxy)-6-[2-(3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl)ethyl]-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4026)

(1s,3ar,3br,5as,7r,9r,9ar,9bs,11r,11ar)-7-(acetyloxy)-11-hydroxy-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate

C34H56O7 (576.4026)

2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5-hydroxy-6-methoxy-3-methylcyclohexa-2,5-diene-1,4-dione

C38H56O4 (576.4178)

(3e,5e,11e,13e)-16-[4-(6-ethyl-2-hydroxy-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C34H56O7 (576.4026)

12-ethyl-6-{15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl}-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-3-ol

C38H48N4O (576.3828)

(1r,9r,12r,19r)-12-ethyl-6-[(15r,17s,19r)-15-ethyl-1,11-diazapentacyclo[9.6.2.0²,⁷.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-2,4,6,8(18)-tetraen-17-yl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2(7),3,5-trien-3-ol

C38H48N4O (576.3828)

7-(acetyloxy)-2,5-dihydroxy-6-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylheptan-3-yl acetate

C34H56O7 (576.4026)

(3r,4s,5s,6s)-6-{[(1r,3as,3bs,7s,9as,9bs,11ar)-9a-(hydroxymethyl)-11a-methyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C34H56O7 (576.4026)

(1r,3as,5as,5br,7ar,9s,11ar,11br,13ar,13br)-5a-[(benzoyloxy)methyl]-9-hydroxy-5b,8,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid

C37H52O5 (576.3815)

(3r,5r)-5-{[(3r,5r)-5-{[(3r,5r)-3,5-dihydroxydecanoyl]oxy}-3-hydroxydecanoyl]oxy}-3-hydroxydecanoic acid

C30H56O10 (576.3873)